Skip to main content
Industry News
FDA finalizes guidelines for bacterial pneumonia drugs
6/25/2020

The FDA released two final guidances on developing drugs for community-acquired bacterial pneumonia and hospital-acquired and ventilator-associated bacterial pneumonia. Both documents include updates to trial populations and statistical considerations for analysis populations.

Full Story: